Process of preparing lamination film, lamination film and heat shield

Patent metadata

Field	Value
Publication number	US-9493707-B2
Application number	US-201113048675-A
Country	US
Kind code	B2
Filing date	Mar 15, 2011
Priority date	Mar 16, 2010
Publication date	Nov 15, 2016
Grant date	Nov 15, 2016

Abstract

A process of preparing a lamination film comprising two or more layers of a fixed cholesteric liquid-crystal phase is disclosed. The process comprises (a) applying a coating liquid of a curable liquid crystal composition comprising a rod-like liquid crystal compound, an alignment-control agent capable of controlling an alignment of the rod-like liquid crystal compound and a solvent to a surface; (b) drying the applied curable liquid crystal composition to form a cholesteric liquid-crystal phase; (c) carrying out a curing reaction of the composition and fixing the cholesteric liquid-crystal phase, thereby to form a lower layer; and (d) repeating the steps (a) to (c) on the lower layer, thereby to form an upper layer; wherein at least a part of the alignment-control agent in the lower layer diffuses into the upper layer.

First claim

The invention claimed is:

1. A process of preparing a lamination film comprising two or more layers of a fixed cholesteric liquid-crystal phase comprising, at least,
(a) applying a curable liquid crystal composition comprising a rod-like liquid crystal compound, an alignment-control agent capable of controlling an alignment of the rod-like liquid crystal compound and a solvent to a surface, wherein the curable liquid crystal composition comprises a chiral agent capable of controlling a twisting direction and/or helical pitch of a cholesteric liquid-crystal phase; and wherein the alignment-control agent is capable of localizing at a film surface and aligning the direction of a long axis of molecules of the rod-like liquid crystal compound parallel to the layer plane;
(b) drying the applied curable liquid crystal composition to form a cholesteric liquid-crystal phase;
(c) carrying out a curing reaction of the composition and fixing the cholesteric liquid-crystal phase, thereby to form a lower layer; and
(d) repeating the steps (a) to (c) on the lower layer, thereby to form an upper layer;
wherein at least a part of the alignment-control agent in the lower layer diffuses into the upper layer after the upper layer curable liquid crystal composition is applied to the lower layer, but before the upper layer curable liquid crystal composition is exposed to the curing reaction,
and
the degree of diffusion of the alignment-control agent from the lower layer into the upper layer is controlled by adjusting the hardness of the lower layer, or
the degree of diffusion of the alignment-control agent from the lower layer into the upper layer is controlled by adjusting the solid content concentration of the upper layer curable liquid crystal composition of the curable liquid crystal composition and/or selecting the solvent.

2. The process of claim 1 , wherein the alignment-control agent which diffuses from the lower layer into the upper layer is reused in the upper layer as an alignment-control agent for a rod-like liquid crystal compound.

3. The process of claim 1 , wherein the concentration of the alignment-control agent for the rod-like liquid crystal compound in the curable liquid crystal composition to be used for forming the upper layer is equal to or smaller than the concentration of the alignment-control agent for the rod-like liquid crystal compound in the curable liquid crystal composition to be used for forming the lower layer.

4. The process of claim 1 , wherein the alignment-control agent in the curable liquid crystal composition is localized at an air-interface of the layer at the time the (c) step is terminated.

5. The process of claim 1 , wherein the degree of diffusion of the alignment-control agent from the lower layer into the upper layer is controlled by adjusting the hardness of the lower layer.

6. The process of claim 5 , wherein the hardness of the lower layer is adjusted by an irradiation amount of active radiation during carrying out the curing reaction and/or by an amount or concentration of a polymerization initiator contained in the curable liquid crystal composition.

7. The process of claim 1 , wherein, in the (c) step, the curing reaction is carried out under a condition so as to allow a part of curable ingredient(s) in the curable liquid crystal composition not to react.

8. The process of claim 7 , wherein, in the (d) step, the curing reaction of said part of curable ingredient(s) in the lower layer is carried out, thereby increasing the hardness of the lower layer.

9. The process of claim 1 , wherein the degree of diffusion of the alignment-control agent from the lower layer into the upper layer is controlled by adjusting the solid content concentration of the upper layer curable liquid crystal composition of the curable liquid crystal composition and/or selecting the solvent.

10. The process of claim 1 , wherein at least the alignment-control agent in the curable liquid crystal composition to be used for forming the lower layer is a compound having at least one fluorine atom.

11. The process of claim 1 , wherein at least the alignment-control agent in the curable liquid crystal composition to be used for forming the lower layer is a compound having at least one perfluoroalkyl group.

12. The process of claim 1 , wherein the alignment-control agent is a compound represented by formula (I), (II), (III) or (IV):

where a plurality of R is same or different and represents a C 1-30 alkoxy group which may be substituted with at least one fluorine atom, and a CH 2 or two or more CH 2 , which are not adjacent to each other, in the alkoxy group may be replaced with —O—, —S—, —OCO—, —COO—, —NR a —, —NR a CO—, —CONR a —, —NR a SO 2 —, or —SO 2 NR a —; R a represents a hydrogen atom or C 1-5 alkyl group; and m1, m2, and m3 each represents an integer from 1 to 5.

13. The process of claim 1 , wherein the curing reactions comprise irradiation of the curable liquid crystal compositions and the irradiation energy amount of active radiation for the curing reaction of the lower layer in the (c) step is less than that for the curing reaction of the upper layer in the (c) step irradiation energy amount.

14. The process of claim 1 , wherein the degree of diffusion of the alignment-control agent from the lower layer into the upper layer is controlled by adjusting the solid content concentration of the upper layer curable liquid crystal composition of the curable liquid crystal composition to 35%.

15. The process of claim 1 , wherein the alignment-control agent is a compound represented by formula (II):

wherein a plurality of Rs are the same or different from each other and each independently represents a C 1-30 alkoxy group which may be substituted with at least one fluorine atom, and a CH 2 or two or more CH 2 , which are not adjacent to each other, in the alkoxy group may be replaced with —O—, —S—, —OCO—, —COO—, —NR a —, —NR a CO—, —CONR a —, —NR a SO 2 —, or —SO 2 NR a —; R a represents a hydrogen atom or C 1-5 alkyl group; and m2 represents an integer from 1 to 5.

16. The process of claim 1 , wherein the alignment-control agent is Compound 7:

17. The process of claim 1 , wherein the alignment-control agent is Compound 6:

Assignees

• Oki Kazuhiro
• Majima Wataru
• Watanabe Hidetoshi
• Ichihashi Mitsuyoshi
• Fujifilm Corp

Inventors

• Oki Kazuhiro
• Majima Wataru
• Watanabe Hidetoshi
• Ichihashi Mitsuyoshi

Classifications

• B32B2038/168

  Removing solvent · CPC title

• C09K2019/0481

  Phenylene substituted in meta position · CPC title

• B32B2037/243

  Coating · CPC title

• Y10T428/31649

  Ester, halide or nitrile of addition polymer · CPC title

• C09K19/32

  containing condensed ring systems, i.e. fused, bridged or spiro ring systems · CPC title